佛慈制药：目前存货水平处于合理范围内

Group 1 - The company announced on November 6 that its inventory level is within a reasonable range and its turnover rate aligns with industry characteristics and averages [2] - The company will closely monitor production capacity and market demand to maintain a balance between production and sales while controlling inventory size [2]